Kalirin Explained

Kalirin, also known as Huntingtin-associated protein-interacting protein (HAPIP), protein duo (DUO), or serine/threonine-protein kinase with Dbl- and pleckstrin homology domain, is a protein that in humans is encoded by the KALRN gene. Kalirin was first identified in 1997 as a protein interacting with huntingtin-associated protein 1. Is also known to play an important role in nerve growth and axonal development.

Kalirin is a member of the Dbl family of proteins and is a Rho guanine nucleotide exchange factor.

It is named after the multiple-handed Hindu goddess Kali for its ability to interact with numerous other proteins. Kalirin's other name, DUO, comes from the fact that it is 98% identical to rat DUO protein and 80.6% identical to a human protein named TRIO. Unlike TRIO, which is expressed in numerous tissues, Kalirin isoforms are mainly found in the brain.

Clinical significance

Several isoforms of Kalirin are produced through alternative splicing. One of the isoforms, Kalirin-7, was found to be necessary for the remodeling of synapses in mature cortical neurons and is thought to be important in the development of schizophrenia, as demonstrated by adolescent development of schizophrenia-like symptoms in kalirin knockout mice. Alzheimer's disease may also be linked to kalirin-7.

The KALRN gene, has been linked to multiple neurological disorders both through large exome and genome sequencing efforts, as well as post mortem and clinical studies.

Several mutations within KALRN have been linked to neurological disease. In autism spectrum disorder, a frameshift mutation was found[1] [2] that is likely to lead to transcript decay, and heterozygosity. Another, found within the second GEF domain, is predicted to be highly deleterious to RhoA-GEF activity and likely affects the function of kalirin9 and 12 isoforms early in neuronal development.[3] A patient harboring a homozygous mutation in kalirin's spectrin repeat domain was found to have severe intellectual disability,[4] and both truncating and missense mutations have been identified in patients with developmental delay.[5] Several intronic variants have been associated with addiction and were found to alter the function of brain regions responsible for reward anticipation.[6] This link to addiction is supported by animal models, where loss of kalirin results in altered cocaine self-administration and synaptic and expression changes in response to cocaine.[7] [8] [9] Perhaps the most compelling genetic links are between kalirin and schizophrenia. Numerous missense mutations in KALRN have been identified in exome sequencing studies of schizophrenia cohorts [10] that are predicted to be deleterious to protein function.

Neuronal studies have provided insight into the mechanisms of some missense mutations, particularly within the GEF domains of KALRN. A mutation found within the Rac-GEF domain was found to induce strong reductions in Rac activation, neuronal branching, and spine density.[11] These effects were mirrored by mutations in the RhoA-GEF domain, producing similar neuronal deficits, but by promoting RhoA-GEF activity.[12] In addition to exome sequencing, post-mortem studies have consistently found alterations in kalirin transcript levels within the brain [13] [14] further supporting a role for kalirin in the etiology of schizophrenia.

In addition to neurodevelopmental disorders, kalirin has been found to be underexpressed in the post-mortem Alzheimer's brain. This loss of kalirin expression was recapitulated in animal models of Alzheimer's disease.[15] [16] Moreover, introduction of kalirin7 into culture [17] or animal models of Alzheimer's disease was able to rescue synaptic and behavioral deficits, suggesting an important role for kalirin in regulating synapse loss and cognitive impairment in Alzheimer's disease.

Function

The majority of kalirin's effects are induced through its catalytic GEF domain signaling. By promoting the release of GDP from Rac and RhoA, it acts as an activator of GTPase signaling within the cell.[18] Although able to activate Rac and RhoA, much of its activity in regulating neuronal morphology has been attributed to Rac-PAK pathway activation.[19] kalirin has found been found to exert control over dendritic arborization,[20] axonal growth,[21] dendritic spine formation [22] and synaptic activity [23] [24] and plasticity.[25] [26] [27] These effects are regulated by protein-protein interactions and post-translational modifications within the non-catalytic domains, and have been shown to exert control over kalirin subcellular targeting and activation.[28]

Kalirin has been found to play a critical role in synaptic activity and plasticity. Loss of KALRN results in decreased nMDAr and AMPAr-mediated mEPSC,[24] and kalirin7 knockout animals show strong deficits in NMDAr mediated long-term potentiation [24] and long term depression.[25] This may be linked to the ability to regulate RAC-PAK signaling and actin dynamics, which in turn can regulate the size and density of dendritic spines.[24] Within dendritic spines, kalirin interacts with multiple disease-related proteins to regulate synapse strength. It directly interacts with the schizophrenia risk factor DISC1 that can act to suppress kalirin function within the spine.[29] Furthermore, kalirin7 directly interacts with the GluN2B subunit of the NMDA receptor and PSD95 [30] within the post-synaptic density.

The importance of KALRN in neurodevelopment is supported by knockout animal models that display profound deficiencies in multiple behavioral tasks. Kalirin knockout animals display reduced GEF activity,[24] dendritic arborization and spine density.[31] These deficits may be linked to the observed reductions in prepulse inhibition, sociability and increased locomotor activity. Notably, loss of kalirin results in deficits in working memory, but not reference memory.[24] [32] The generation of a kalirin7 specific knockout animal model revealed similar deficits in spine density,[33] suggesting a central role of kalirin7 in regulating neuronal connectivity. Both full and kalirin7 specific knockout animals show decreased anxiety-like behavior and impaired contextual fear learning.[34]

Expression

Multiple isoforms, arising from alternate splicing and promoter usage, display varying tissue and developmental expression.[35] [36] Control over kalirin expression is exerted through the use of alternate promoters which produce alternate start sites and restrict expression to specific neuronal subpopulations, and alter kalirin activity within neurons.[37] [38] During early development, the long kalirin9 and 12 isoforms are predominant in the brain. These isoforms contain both a Rac and a RhoA selective GEF domain, and control axonal growth and dendritic branching. Kalirin9 and 12 are also expressed ubiquitously throughout the body [39] and have functions outside the brain. However, during neurodevelopment, the kalirin7 isoform is preferentially expressed during periods of synaptogenesis, and this isoform displays highly restricted cortical expression.[40] Kalirin7 expresses only the N-terminal domains, including the Rac-GEF domain along with a c-terminal PDZ-binding domain that strongly targets kalirin7 to the post-synaptic density. It is likely this subcellular distribution is vital to kalirin7 function, as this isoform exerts control dendritic spine density and synaptic plasticity. It is likely that mutations that result in deregulation of kalirin function within the brain is responsible for the role of kalirin within multiple neurological disorders.

External links

Notes and References

  1. Lek. Monkol. Diab. Nicholas . vanc . 2019-07-15. Faculty Opinions recommendation of Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. . Faculty Opinions . 10.3410/f.734542901.793562583. 199641906 . free .
  2. Lek M, Diab N . 2019-07-15. Faculty Opinions recommendation of Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. . Faculty Opinions . 10.3410/f.734542901.793562583. 199641906 . free .
  3. Leblond CS, Cliquet F, Carton C, Huguet G, Mathieu A, Kergrohen T, Buratti J, Lemière N, Cuisset L, Bienvenu T, Boland A, Deleuze JF, Stora T, Biskupstoe R, Halling J, Andorsdóttir G, Billstedt E, Gillberg C, Bourgeron T . 6 . Both rare and common genetic variants contribute to autism in the Faroe Islands . npj Genomic Medicine . 4 . 1 . 2018-07-06 . 30675382 . 10.1038/s41525-018-0075-2. 10.1101/363853 . 6341098 . 196670411 .
  4. Makrythanasis P, Guipponi M, Santoni FA, Zaki M, Issa MY, Ansar M, Hamamy H, Antonarakis SE . 6 . Exome sequencing discloses KALRN homozygous variant as likely cause of intellectual disability and short stature in a consanguineous pedigree . Human Genomics . 10 . 1 . 26 . July 2016 . 27421267 . 10.1186/s40246-016-0082-2 . 4947303 . free .
  5. June 2017. Prevalence and Architecture of De Novo Mutations in Developmental Disorders. Obstetrical & Gynecological Survey. 72. 6. 340–341. 10.1097/ogx.0000000000000460. 79759435. 0029-7828.
  6. Peña-Oliver Y, Carvalho FM, Sanchez-Roige S, Quinlan EB, Jia T, Walker-Tilley T, Rulten SL, Pearl FM, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod PJ, Flor H, Gallinat J, Garavan H, Heinz A, Gowland P, Paillere Martinot ML, Paus T, Rietschel M, Robbins TW, Smolka MN, Schumann G, Stephens DN . 6 . Mouse and Human Genetic Analyses Associate Kalirin with Ventral Striatal Activation during Impulsivity and with Alcohol Misuse . Frontiers in Genetics . 7 . 52 . 2016-04-07 . 27092175 . 10.3389/fgene.2016.00052 . 4823271 . free .
  7. Kiraly DD, Nemirovsky NE, LaRese TP, Tomek SE, Yahn SL, Olive MF, Eipper BA, Mains RE . 6 . Constitutive knockout of kalirin-7 leads to increased rates of cocaine self-administration . Molecular Pharmacology . 84 . 4 . 582–90 . October 2013 . 23894151 . 10.1124/mol.113.087106 . 3781382 .
  8. 2014-01-08. Correction: Wang et al., Kalirin-7 Mediates Cocaine-Induced AMPA Receptor and Spine Plasticity, Enabling Incentive Sensitization. Journal of Neuroscience. 34. 2. 688. 10.1523/jneurosci.4822-13.2014. 3953587 . 219222516. 0270-6474. free.
  9. Kiraly DD, Ma XM, Mazzone CM, Xin X, Mains RE, Eipper BA . Behavioral and morphological responses to cocaine require kalirin7 . Biological Psychiatry . 68 . 3 . 249–55 . August 2010 . 20452575 . 10.1016/j.biopsych.2010.03.024 . 2907465 .
  10. Burdon KP . 2014-03-07. Faculty Opinions recommendation of A polygenic burden of rare disruptive mutations in schizophrenia. . Faculty Opinions . 10.3410/f.718252264.793491785. free.
  11. Russell TA, Blizinsky KD, Cobia DJ, Cahill ME, Xie Z, Sweet RA, Duan J, Gejman PV, Wang L, Csernansky JG, Penzes P . 6 . A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness . Nature Communications . 5 . 1 . 4858 . September 2014 . 25224588 . 10.1038/ncomms5858 . 4166532 . 2014NatCo...5.4858R .
  12. Kushima I, Nakamura Y, Aleksic B, Ikeda M, Ito Y, Shiino T, Okochi T, Fukuo Y, Ujike H, Suzuki M, Inada T, Hashimoto R, Takeda M, Kaibuchi K, Iwata N, Ozaki N . 6 . Resequencing and association analysis of the KALRN and EPHB1 genes and their contribution to schizophrenia susceptibility . Schizophrenia Bulletin . 38 . 3 . 552–60 . May 2012 . 21041834 . 10.1093/schbul/sbq118 . 3329972 .
  13. Narayan S, Tang B, Head SR, Gilmartin TJ, Sutcliffe JG, Dean B, Thomas EA . Molecular profiles of schizophrenia in the CNS at different stages of illness . Brain Research . 1239 . 235–48 . November 2008 . 18778695 . 10.1016/j.brainres.2008.08.023 . 2783475 .
  14. Hill JJ, Hashimoto T, Lewis DA . Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia . Molecular Psychiatry . 11 . 6 . 557–66 . June 2006 . 16402129 . 10.1038/sj.mp.4001792 . 614799 . free .
  15. Nairn A, Leslie S . 2018-12-19. Faculty Opinions recommendation of Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies. . Faculty Opinions . 10.3410/f.734327820.793554446. 91384966 . free .
  16. Cissé M, Duplan E, Lorivel T, Dunys J, Bauer C, Meckler X, Gerakis Y, Lauritzen I, Checler F . 6 . The transcription factor XBP1s restores hippocampal synaptic plasticity and memory by control of the Kalirin-7 pathway in Alzheimer model . Molecular Psychiatry . 22 . 11 . 1562–1575 . November 2017 . 27646263 . 10.1038/mp.2016.152 . 5658671 .
  17. Xie Z, Shapiro LP, Cahill ME, Russell TA, Lacor PN, Klein WL, Penzes P . Kalirin-7 prevents dendritic spine dysgenesis induced by amyloid beta-derived oligomers . The European Journal of Neuroscience . 49 . 9 . 1091–1101 . May 2019 . 30565792 . 10.1111/ejn.14311 . 6559832 .
  18. Penzes P, Johnson RC, Kambampati V, Mains RE, Eipper BA . Distinct roles for the two Rho GDP/GTP exchange factor domains of kalirin in regulation of neurite growth and neuronal morphology . The Journal of Neuroscience . 21 . 21 . 8426–34 . November 2001 . 11606631 . 6762781 . 10.1523/jneurosci.21-21-08426.2001 .
  19. Bryan Roth . Jones KA, Srivastava DP, Allen JA, Strachan RT, Roth BL, Penzes P . Rapid modulation of spine morphology by the 5-HT2A serotonin receptor through kalirin-7 signaling . Proceedings of the National Academy of Sciences of the United States of America . 106 . 46 . 19575–80 . November 2009 . 19889983 . 2780750 . 10.1073/pnas.0905884106 . 2009PNAS..10619575J . free .
  20. Yan Y, Eipper BA, Mains RE . Kalirin-9 and Kalirin-12 Play Essential Roles in Dendritic Outgrowth and Branching . Cerebral Cortex . 25 . 10 . 3487–501 . October 2015 . 25146373 . 4585498 . 10.1093/cercor/bhu182 .
  21. May V, Schiller MR, Eipper BA, Mains RE . Kalirin Dbl-homology guanine nucleotide exchange factor 1 domain initiates new axon outgrowths via RhoG-mediated mechanisms . The Journal of Neuroscience . 22 . 16 . 6980–90 . August 2002 . 12177196 . 10.1523/jneurosci.22-16-06980.2002 . 6757900 . 15927856 . free .
  22. Xie Z, Srivastava DP, Photowala H, Kai L, Cahill ME, Woolfrey KM, Shum CY, Surmeier DJ, Penzes P . 6 . Kalirin-7 controls activity-dependent structural and functional plasticity of dendritic spines . Neuron . 56 . 4 . 640–56 . November 2007 . 18031682 . 2118058 . 10.1016/j.neuron.2007.10.005 .
  23. Herring BE, Nicoll RA . Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP . Proceedings of the National Academy of Sciences of the United States of America . 113 . 8 . 2264–9 . February 2016 . 26858404 . 4776457 . 10.1073/pnas.1600179113 . 2016PNAS..113.2264H . free .
  24. Cahill ME, Xie Z, Day M, Photowala H, Barbolina MV, Miller CA, Weiss C, Radulovic J, Sweatt JD, Disterhoft JF, Surmeier DJ, Penzes P . 6 . Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes . Proceedings of the National Academy of Sciences of the United States of America . 106 . 31 . 13058–63 . August 2009 . 19625617 . 2722269 . 10.1073/pnas.0904636106 . 2009PNAS..10613058C . free .
  25. Lemtiri-Chlieh F, Zhao L, Kiraly DD, Eipper BA, Mains RE, Levine ES . Kalirin-7 is necessary for normal NMDA receptor-dependent synaptic plasticity . BMC Neuroscience . 12 . 1 . 126 . December 2011 . 22182308 . 3261125 . 10.1186/1471-2202-12-126 . free .
  26. Kiraly DD, Lemtiri-Chlieh F, Levine ES, Mains RE, Eipper BA . Kalirin binds the NR2B subunit of the NMDA receptor, altering its synaptic localization and function . The Journal of Neuroscience . 31 . 35 . 12554–65 . August 2011 . 21880917 . 3172699 . 10.1523/jneurosci.3143-11.2011 .
  27. LaRese TP, Yan Y, Eipper BA, Mains RE . Using Kalirin conditional knockout mice to distinguish its role in dopamine receptor mediated behaviors . BMC Neuroscience . 18 . 1 . 45 . May 2017 . 28535798 . 5442696 . 10.1186/s12868-017-0363-2 . free .
  28. Paskus JD, Tian C, Fingleton E, Shen C, Chen X, Li Y, Myers SA, Badger JD, Bemben MA, Herring BE, Roche KW . 6 . Synaptic Kalirin-7 and Trio Interactomes Reveal a GEF Protein-Dependent Neuroligin-1 Mechanism of Action . Cell Reports . 29 . 10 . 2944–2952.e5 . December 2019 . 31801062 . 10.1016/j.celrep.2019.10.115 . 9012321 . free .
  29. Hayashi-Takagi A, Takaki M, Graziane N, Seshadri S, Murdoch H, Dunlop AJ, Makino Y, Seshadri AJ, Ishizuka K, Srivastava DP, Xie Z, Baraban JM, Houslay MD, Tomoda T, Brandon NJ, Kamiya A, Yan Z, Penzes P, Sawa A . 6 . Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1 . Nature Neuroscience . 13 . 3 . 327–32 . March 2010 . 20139976 . 2846623 . 10.1038/nn.2487 .
  30. Penzes P, Johnson RC, Sattler R, Zhang X, Huganir RL, Kambampati V, Mains RE, Eipper BA . 6 . The neuronal Rho-GEF Kalirin-7 interacts with PDZ domain-containing proteins and regulates dendritic morphogenesis . Neuron . 29 . 1 . 229–42 . January 2001 . 11182094 . 10.1016/s0896-6273(01)00193-3 . 7014018 . free .
  31. Xie Z, Cahill ME, Penzes P . Kalirin loss results in cortical morphological alterations . Molecular and Cellular Neurosciences . 43 . 1 . 81–9 . January 2010 . 19800004 . 10.1016/j.mcn.2009.09.006 . 2818244 .
  32. Vanleeuwen JE, Penzes P . Long-term perturbation of spine plasticity results in distinct impairments of cognitive function . Journal of Neurochemistry . 123 . 5 . 781–9 . December 2012 . 22862288 . 10.1111/j.1471-4159.2012.07899.x . 3493825 .
  33. Xie Z, Cahill ME, Radulovic J, Wang J, Campbell SL, Miller CA, Sweatt JD, Penzes P . 6 . Hippocampal phenotypes in kalirin-deficient mice . Molecular and Cellular Neurosciences . 46 . 1 . 45–54 . January 2011 . 20708080 . 10.1016/j.mcn.2010.08.005 . 3576140 .
  34. Mandela P, Yankova M, Conti LH, Ma XM, Grady J, Eipper BA, Mains RE . Kalrn plays key roles within and outside of the nervous system . BMC Neuroscience . 13 . 1 . 136 . November 2012 . 23116210 . 10.1186/1471-2202-13-136 . 3541206 . free .
  35. Johnson RC, Penzes P, Eipper BA, Mains RE . Isoforms of kalirin, a neuronal Dbl family member, generated through use of different 5'- and 3'-ends along with an internal translational initiation site . The Journal of Biological Chemistry . 275 . 25 . 19324–33 . June 2000 . 10777487 . 10.1074/jbc.m000676200 . 2718066 . free .
  36. McPherson CE, Eipper BA, Mains RE . Genomic organization and differential expression of Kalirin isoforms . Gene . 284 . 1–2 . 41–51 . February 2002 . 11891045 . 10.1016/s0378-1119(02)00386-4 .
  37. Mains RE, Kiraly DD, Eipper-Mains JE, Ma XM, Eipper BA . Kalrn promoter usage and isoform expression respond to chronic cocaine exposure . BMC Neuroscience . 12 . 1 . 20 . February 2011 . 21329509 . 10.1186/1471-2202-12-20 . 3048553 . free .
  38. Miller MB, Vishwanatha KS, Mains RE, Eipper BA . An N-terminal Amphipathic Helix Binds Phosphoinositides and Enhances Kalirin Sec14 Domain-mediated Membrane Interactions . The Journal of Biological Chemistry . 290 . 21 . 13541–55 . May 2015 . 25861993 . 10.1074/jbc.m115.636746 . 4505600 . free .
  39. Hansel DE, Quiñones ME, Ronnett GV, Eipper BA . Kalirin, a GDP/GTP exchange factor of the Dbl family, is localized to nerve, muscle, and endocrine tissue during embryonic rat development . The Journal of Histochemistry and Cytochemistry . 49 . 7 . 833–44 . July 2001 . 11410608 . 10.1177/002215540104900704 . 14973698 . free .
  40. Mandela P, Ma XM . Kalirin, a key player in synapse formation, is implicated in human diseases . Neural Plasticity . 2012 . 728161 . 2012 . 22548195 . 10.1155/2012/728161 . 3324156 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Kalirin".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.